Alchemia
Eight Mile Plains
About Alchemia
Alchemia Limited is a listed Australian biopharmaceutical company (ASX:ACL) with an FDA approved drug (Fondaparinux sodium) and a late stage oncology product pipeline derived from the HyACT platform. In addition, Alchemia has a drug discovery platform, VAST®, derived from Alchemia’s chemistry expertise.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Delisted
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $10.5M
- Funding stage: M&A
- Last round: Post-IPO Equity (Mar 2013)
- Ticker: asx:ACL
- Website: alchemia.com.au
- Phone: +61 7 3340 0200
Industries & Categories
Biopharma, Biotechnology, Health Care, Oncology
Social Profiles
Canonical: https://fsome.com/organization/alchemia-239194 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.